Anna - you are spot on. having met and listened to both Peter (ex ceo) and Shane, both are rookie in pharma, tga, clinical trial space. the scientific gap within this org is astounding. board led by chair who doesn't have skin in the game either. blind has been leading blind..astounding the amount of investment gone here without a competent oversight..
Anna - you are spot on. having met and listened to both Peter...
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.34M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.8¢ | 3.7¢ | $3.09K | 82.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 1030441 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 125000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| CAN (ASX) Chart |